Aim and Scope
Submission of Manuscript
Materials and Methods
Aim and Scope
International Journal of Drug Formulation and Research (IJDFR)
is a peer-reviewed multidisciplinary online open access journal published bimonthly. IJDFR publishes original
research articles in pharmaceutical fields (pharmacology, pharmaceutics, pharmaceutical technology,
pharmaceutical dispensing, pharmaceutical analysis, medicinal chemistry, biopharmaceutics,
pharmacokinetics, toxicology, quality assurance pharmacognosy, phytochemistry, pharmacy practice,
drug regulatory affair and pharmaceutical management). The journal accepts Review Articles and
Submission of Manuscript
Authors are invited to submit their manuscripts through online along with a
covering letter preferably by the corresponding author. Each manuscript will be provided
with a manuscript ID and all correspondence is done through e-mail. Please always refer to
the manuscript ID for any other enquiries.
Manuscript should be typewritten in 12 font size, double-spaced, with margins of at least one
inch on all sides. Pages should be numbered consecutively, starting with the title page and
the matter arranged in the following order: Title page, Sections (Abstract, Keywords, Introduction,
Materials and Methods, Results, Discussion or Results and Discussion, Conclusions, Acknowledgements,
References, Illustrations (Tables and figures along with caption and legends) and Tables and Figures
captions and legends. Original Articles should have more than 14 pages, Review Articles in the range
of 14-30 pages.
Title page contains title of the manuscript in bold face, title case (font size 14), names of the
authors in normal face, title case (font size 12) followed by the address of authors in normal face,
lower case (font size 12). Names of the authors should appear as initials followed by surnames.
Full names may be given in some instances to avoid confusion. Followed by the author names, please
provide the complete postal address or addresses with pin code number of the place(s), where the
research work has been carried out. If the publication originates from several institutes, the
affiliation of each author should be clearly stated by using superscript Arabic numbers after the
name and before the institute. The author to whom correspondence should be directed must be indicated
with an asterisk. At the bottom left corner of this page, please mention “*For correspondence” and
provide a functional e-mail address of the corresponding author to whom all correspondence is to be sent.
An abstract not exceeding 250 words should be provided typed on a separate sheet. Abstract should
include aims, methods, results and conclusion.
Up to 3-5 keywords must be provided in alphabetical order, preferably taken from Index Medicus. These
keywords should be typed at the end of the abstract.
It should be a concise statement of the background to the work presented, including relevant earlier
work, suitably referenced. It should be started in a separate page after keywords.
Materials and Methods
It shall be started as a continuation to introduction on the same page. All important materials and
equipments, the manufacturer’s name and, if possible, the location should be provided. The main methods
used shall be briefly described, citing references. New methods or substantially modified methods may
be described in sufficient detail. The statistical method and the level of significance chosen shall be
The important results of the work should be clearly stated and illustrated where necessary by tables and
figures. The statistical treatment of data and significance level of the factors should be stated wherever
necessary. Data that is not statistically significant need only to be mentioned in the text -
no illustration is necessary.
This section should deal with the interpretation of results, making the readers to understanding of the
problem taken and should be logical. The discussion should state the scope of the results, which need
to be further explored. Results and discussion of the work can also be combined under one section,
Results and Discussion.
Concisely summarizes the principal conclusions of the work and highlights the wider implications.
This section should not merely duplicate the abstract.
Acknowledgements as well as information regarding funding sources should be provided.
Citations of literature within the text must be presented in numerical order and should be set in square
brackets. The cited literature are also collected in numerical order at the end of the
manuscript under the heading “References”. Titles of journals should be abbreviated according to the
practice of Chemical Abstracts. The abbreviated title and the volume number should appear in italics.
Only the papers and books that have been published or in press may be cited. Please note that website
addresses must not be included as a reference, but should be inserted in the text directly after the
information to which they refer. Please note the following examples.
- Patel , S. A., Shraminth , P. S., journal of . Pharmacochemistry. 1990, 22, 21 – 41.
- Shanghi , K., Hagino, M., Kotaki, H., Iga, T., J.Pharmabiz. , 1998, 120, 15 – 25.
- Myers, R. H., Montgomery, D., Drug regulatory affair, New York 1997.
Chapter in a book :
- Nathan, R. B., Handbook of Modern Pharmaceutical Calculations, Uco Press, USA 2004, pp. 15 – 44.
Page proofs are sent to the designated author through e-mail. They must be carefully checked and
returned the revised manuscript within one week of receipt.
Authors are asked to sign a warranty and copyright agreement upon acceptance of their manuscript,
before the manuscript can be published.
Submission of your paper to this journal implies that the paper is not under submission for
publication elsewhere. Material which has been previously copyrighted, published, or accepted
for publication will not be considered for publication in this journal. Submission of a
manuscript is interpreted as a statement of certification that no part of the manuscript
is copyrighted by any other publisher nor is under review by any other formal publication.
By submitting your manuscript to us, you agree on copyright guidelines. It is your
responsibility to ensure that your manuscript does not cause any copyright infringements,
defamation, and other problems. Submitted papers are assumed to contain no proprietary
material unprotected by patent or patent application; responsibility for technical content
and for protection of proprietary material rests solely with the author(s) and their
organizations and is not the responsibility of the IJDFR or its Editorial Staff. The main
author is responsible for ensuring that the article has been seen and approved by all the
other authors. It is the responsibility of the author to obtain all necessary copyright release
permissions for the use of any copyrighted materials in the manuscript prior to the submission.